Showing results (51-60 of 88) with videos related to
Sort By:
Pageof 9
European Heart Journal Open|September 4, 2025
Fuelling aortic stenosis: the integral role of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3-mediated glycolysis in Lp(a)-induced valve inflammationMerel Peletier, Lubna Ali, Kim Dzobo, et al.Journal of Clinical Lipidology|July 5, 2020
Genetic variants in SUSD2 are associated with the risk of ischemic heart diseaseCaroline S Bruikman, Nawar Dalila, Julian C van Capelleveen, et al.European Heart Journal|August 3, 2021
Impact of cholesterol on proinflammatory monocyte production by the bone marrowLotte C A Stiekema, Lisa Willemsen, Yannick Kaiser, et al.Atherosclerosis|May 12, 2025
Accelerated atherosclerosis associated with immune checkpoint inhibitors: a systematic review and meta-analysis of pre-clinical studiesAnniek Strijdhorst, Winnie G Vos, Laura A Bosmans, et al.Atherosclerosis|February 3, 2022
Reduced baroreflex sensitivity and increased splenic activity in patients with severe obstructive sleep apneaYannick Kaiser, Kim E Dzobo, Madeline J L Ravesloot, et al.Clinical Epigenetics|November 11, 2020
BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetesSylwia Wasiak, Kim E Dzobo, Brooke D Rakai, et al.Frontiers in Cell and Developmental Biology|December 7, 2020
Inhibition of PFKFB3 Hampers the Progression of Atherosclerosis and Promotes Plaque StabilityKikkie Poels, Johan G Schnitzler, Farahnaz Waissi, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 25, 2017
Remnant Cholesterol Elicits Arterial Wall Inflammation and a Multilevel Cellular Immune Response in HumansSophie J Bernelot Moens, Simone L Verweij, Johan G Schnitzler, et al.EJNMMI Research|November 19, 2024
First-in-human study of 99mTc-labeled fucoidan, a SPECT tracer targeting P-selectinReindert F Oostveen, Kang H Zheng, Yannick Kaiser, et al.Diabetologia|August 15, 2023
Atorvastatin lowers 68Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetesReindert F Oostveen, Yannick Kaiser, Mia R Ståhle, et al.Pageof 9